Trials / Completed
CompletedNCT05250830
TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)
Non-invasive bioELEctroniC Treatment foR pOst-cesarean paiN (ELECTRON)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized trial of 134 individualized post-cesarean delivery who will be randomized to twice daily use of non-invasive bioelectronic treatment with TrueRelief device or identical appearing sham device for post-cesarean pain management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TrueRelief device | TrueRelief is an FDA-cleared treatment for chronic intractable pain, and as an adjunctive procedure in the management of post-surgical and post-traumatic acute pain. This 20,000 Hz high frequency electrical procedure is provided by clinicians trained in the use of the device and delivered via handheld steel-tipped probes to the source of pain and where pain is experienced. |
| DEVICE | Sham TrueRelief device | The placebo device looks and operates identically to the experimental TrueRelief device but will not emit any high frequency current. |
Timeline
- Start date
- 2022-04-18
- Primary completion
- 2023-03-16
- Completion
- 2023-04-16
- First posted
- 2022-02-22
- Last updated
- 2024-06-06
- Results posted
- 2024-06-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05250830. Inclusion in this directory is not an endorsement.